This is unpublished

Alexandre V.
Hirayama
M.D.

Alexandre Hirayama

 Photo: Fred Hutch

Physician & Research Faculty
Pinned
Academic
Assistant Professor, Clinical Research Division, Fred Hutch Cancer Center
Assistant Professor, Division of Hematology and Oncology, University of Washington
Affiliate Investigator, Translational Science and Therapeutics Division, Fred Hutch
Sites of Practice
Fred Hutch Cancer Center – Sloan Clinic
Fred Hutch Cancer Center at UW Medical Center – Montlake

EDUCATION, TRAINING, BOARD CERTIFICATIONS

  • MD, University of Brasilia, Brazil
  • Residency in Internal Medicine, University of São Paulo School of Medicine
  • Fellowship in Hematology and Transfusion Medicine, University of São Paulo School of Medicine
  • Fellowship in Hematopoietic Cell Transplantation, University of São Paulo School of Medicine
  • Visiting physician at the Blood and Marrow Transplant Program, Fred Hutch Cancer Center
  • Post-doctoral research fellow, clinical research division, Fred Hutchinson Cancer Center 
  • Physician-scientist Scholar, Immunotherapy Integrated Research Center, Fred Hutch Cancer Center

CLINICAL EXPERTISE
General medical oncology

  • Hematopoietic stem cell transplantation
  • Cellular Immunotherapy

AFFILIATIONS

PUBLICATION

MyNCBI

RESEARCH AND/OR CLINICAL INTERESTS 

Dr. Alexandre V. Hirayama is a hematologist-oncologist specializing in the care of patients with blood cancers undergoing blood and marrow transplantation and cellular immunotherapies. Much of his focus is on chimeric antigen receptor T-cell therapy (or CAR T-cell therapy), a cutting-edge treatment involving the transfer of engineered disease-fighting immune cells into a patient. Dr. Hirayama leverages state-of-the-art technologies to gain a comprehensive understanding of the factors impacting outcomes following these immunotherapies. Through his work, he aims to design and conduct clinical trials to hasten the development of more effective immunotherapies, ultimately improving patient outcomes.